Chemotherapy of ependymoma

Handbook of Brain Tumor Chemotherapy

Volumn , Issue , 2006, Pages 426-431

  Malkin, Mark G ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56749111590     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088410-0/50068-8     Document Type: Chapter

References (38)

1. Grill J., Pascal C., Chantal K. Childhood ependymoma. A systematic review of treatment options and strategies. Pediatr Drugs 2003, 5(8):533-543.
2. Moynihan T.J. Ependymal tumors. Curr Treat Options Oncol 2003, 4:517-523.
3. Chamberlain M.C. Ependymomas. Curr Neurol Neurosci Rep 2003, 3:193-199.
4. Merchant T.E. Current management of childhood ependymoma. Oncology 2002, 16(5):629-644.
5. Bouffet E., Foreman N. Chemotherapy for intracranial ependymomas. Child's Nerv Syst 1999, 15:563-570.
6. Siffert J., Allen J.C. Chemotherapy in recurrent ependymoma. Pediatr Neurosurg 1998, 28:314-319.
7. Souweidane M.M., Bouffet E., Finlay J. The role of chemotherapy in newly diagnosed ependymoma of childhood. Pediatr Neurosurg 1998, 28:273-278.
8. Robertson P.L., Zeltzer P.M., Boyett J.M., et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 1998, 88:695-703.
9. Bouffet E., Perilongo G., Canete A., Massimino M. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 1998, 30:319-331.
10. Geyer J.R., Zeltzer P.M., Boyett J.M., et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Children's Cancer Group. J Clin Oncol 1994, 12(8):1607-1615.
11. Grill J., Kalifa C., Doz F., et al. A high-dose busulfanthiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. Pediatr Neurosurg 1996, 25:7-12.
12. Mason W.P., Goldman S., Yates A.J., Boyett J., Li H., Finlay J.L. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma. A report of the Children's Cancer Group. J Neurooncol 1998, 37:135-143.
13. Evans A.E., Anderson J.R., Lefkowitz-Boudreaux I.B., Finlay J.L. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or. Med Pediatr Oncol 1996, 27:8-14.
14. Needle M.N., Goldwein J.W., Grass J., et al. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 1997, 80(2):341-347.
15. Fouladi M., Baruchel S., Chan H., et al. Use of adjuvant ICE chemotherapy in the treatment of anaplastic ependymoma. Childs Nerv Syst 1998, 14:590-595.
16. Chamberlain M.C. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide. Pediatr Neurol 2001, 24(2):117-121.
17. Timmerman B., Kortmann R.-D., Kühl J., et al. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 2000, 46(2):287-295.
18. Grill J., Le Deley M.-C., Gambarelli D., et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 2001, 19(5):1288-1296.
19. Brandes A.A., Cavallo G., Reni M., et al. A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. Cancer 2005, 104(1):143-148.
20. Sexauer C.L., Khan A., Burger P.C., et al. Cisplatin in recurrent pediatric brain tumors. A POG phase II study. A Pediatric Oncology Group study. Cancer 1985, 56(7):1497-1501.
21. Gaynon P.S., Ettinger L.J., Baum E.S., Siegel S.E., Krailo M.D., Hammond G.D. Carboplatin in childhood brain tumors. A Children's Cancer Study Group phase II trial. Cancer 1990, 66(12):2465-2469.
22. Friedman H.S., Krischer J.P., Burger P., et al. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Pediatric Oncology Group randomized phase II study. J Clin Oncol 1992, 10(2):249-256.
23. Ragab A.A.H., Burger P., Badnitsky S., Krischer J., Van Eys J. PCNU in the treatment of recurrent medulloblastoma and ependymoma. J Neurooncol 1986, 3:341-342.
24. Ettinger L.J., Ru N., Krailo M., Ruccione K.S., Krivit W., Hammond G.D. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: A report from the Children's Cancer Study Group. J Neurooncol 1990, 9:69-76.
25. Chastagner P., Sommelet-Olive D., Kalifa C., et al. Phase II study of ifosfamide in childhood brain tumors: A report by the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol 1993, 21:49-53.
26. Heideman R.L., Douglass E.C., Langston J.A., et al. A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: A Pediatric Oncology Group study. J Neurooncol 1995, 25:77-84.
27. Heideman R.L., Packer R.J., Reaman G.H., et al. A phase II evaluation of thiotepa in pediatric central nervous system malignancies. Cancer 1993, 72(1):271-275.
28. Needle M.N., Molloy P.T., Geyer J.R., et al. Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors. Med Pediatr Oncol 1997, 29:28-32.
29. White L., Kellie S., Gray E., et al. Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. J Pediatr Hematol/Oncol 1998, 20(2):125-130.
30. Arndt C.A.S., Krailo M.D., Steinherz L., Scheithauer B., Liu-Mares W., Reaman G.H. A phase II clinical trial of idarubicin administered to children with relapsed brain tumors. Cancer 1998, 83(4):813-816.
31. Kadota R.P., Stewart C.F., Horn M., et al. Topotecan for the treatment of recurrent or progressive central nervous system tumors - a Pediatric Oncology Group phase II study. J Neurooncol 1999, 43:43-47.
32. Frangoul H., Ames M.M., Mosher R.B., et al. Phase I study of topotecan administered as a 21-day continuous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group. Clin Cancer Res 1999, 5:3956-3962.
33. Mulne A.F., Ducore J.M., Elterman R.D., et al. Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. J Pediatr Hematol/Oncol 2000, 22(1):41-44.
34. Hurwitz C.A., Strauss L.C., Kepner J., et al. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: A Pediatric Oncology phase II study. J Pediatr Hematol/Oncol 2001, 23(5):277-281.
35. Turner C.D., Gururangan S., Eastwood J., et al. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience. Neuro-Oncol 2002, 4:102-108.
36. Hargrave D.R., Bouffet E., Gammon J., Tariq N., Grant R.M., Baruchel S. Phase I study of fotemustine in pediatric patients with refractory brain tumors. Cancer 2002, 95(6):1294-1301.
37. Rojas-Marcos I., Calvet D., Janoray P., Delattre J.Y. Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isoretinoin. Neurology 2003, 61:1019-1020.
38. WolffJ.E.A., Finlay J.L. High-dose chemotherapy in childhood brain tumors. Onkologie 2004, 27:239-245.